Epinephrine use in COVID-19: friend or foe?
作者信息
Luo Pan, Liu Dong, Li Juan
机构信息
Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
出版信息
Eur J Hosp Pharm. 2021 Jan;28(1):e1. doi: 10.1136/ejhpharm-2020-002295. Epub 2020 May 29.
Abstract
摘要
相似文献
1
Epinephrine use in COVID-19: friend or foe?新冠疫情中肾上腺素的使用：是福是祸？
Eur J Hosp Pharm. 2021 Jan;28(1):e1. doi: 10.1136/ejhpharm-2020-002295. Epub 2020 May 29.
2
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.SARS-CoV-2 激活的肥大细胞释放组织胺，增加白细胞介素-1 水平，导致 COVID-19 中的细胞因子风暴和炎症反应。
J Biol Regul Homeost Agents. 2020;34(5):1629-1632. doi: 10.23812/20-2EDIT.
3
Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the Caused by SARS-CoV-2?己酮可可碱和别嘌呤醇：预防 SARS-CoV-2 引起的疾病的潜在药物？
Curr Pharm Des. 2020;26(35):4515-4521. doi: 10.2174/1381612826666200811180232.
4
Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.在细胞因子释放综合征背景下 SARS-CoV-2 感染的诊断。
Expert Rev Mol Diagn. 2020 Nov;20(11):1087-1097. doi: 10.1080/14737159.2020.1830760. Epub 2020 Oct 12.
5
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.严重急性呼吸综合征冠状病毒 2 感染：细胞因子在 COVID-19 疾病中的作用。
Cytokine Growth Factor Rev. 2020 Aug;54:62-75. doi: 10.1016/j.cytogfr.2020.06.001. Epub 2020 Jun 2.
6
Prevention of the cytokine storm in COVID-19.新型冠状病毒肺炎细胞因子风暴的预防
Lancet Infect Dis. 2021 Jan;21(1):25-26. doi: 10.1016/S1473-3099(20)30376-5. Epub 2020 May 7.
7
Azithromycin in patients with COVID-19: Friend or foe?阿奇霉素用于新冠肺炎患者：是友还是敌？
Clin Microbiol Infect. 2021 Jan;27(1):136-137. doi: 10.1016/j.cmi.2020.09.047. Epub 2020 Sep 29.
8
COVID-19 cytokine storm: what is in a name?新冠病毒细胞因子风暴：名称中有何含义？
Ann Rheum Dis. 2021 Jan;80(1):3-5. doi: 10.1136/annrheumdis-2020-219448. Epub 2020 Nov 17.
9
Immune cell puzzle COVID-19: how do SARS-CoV infections contribute to psychiatric diseases?免疫细胞谜题与新冠病毒：严重急性呼吸综合征冠状病毒感染如何引发精神疾病？
Eur Arch Psychiatry Clin Neurosci. 2020 Sep;270(6):643-644. doi: 10.1007/s00406-020-01179-y.
10
Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification.COVID-19 患者经体外血液净化治疗后，细胞因子风暴得到成功控制，病情得到恢复。
Int J Infect Dis. 2020 Jul;96:618-620. doi: 10.1016/j.ijid.2020.05.065. Epub 2020 May 26.
引用本文的文献
1
Association of vasopressors with mortality in critically ill patients with COVID-19: a systematic review and meta-analysis.血管升压药与 COVID-19 危重症患者死亡率的关联：一项系统评价与荟萃分析
Anesthesiol Perioper Sci. 2023;1(2):10. doi: 10.1007/s44254-023-00013-7. Epub 2023 Apr 23.
2
Generic model to unravel the deeper insights of viral infections: an empirical application of evolutionary graph coloring in computational network biology.通用模型揭示病毒感染的更深层次见解：进化图着色在计算网络生物学中的实证应用。
BMC Bioinformatics. 2024 Feb 16;25(1):74. doi: 10.1186/s12859-024-05690-0.
3
Sniffing out safety: canine detection and identification of SARS-CoV-2 infection from armpit sweat.嗅出安全：犬类从腋窝汗液中检测和识别新冠病毒感染
Front Med (Lausanne). 2023 Sep 19;10:1185779. doi: 10.3389/fmed.2023.1185779. eCollection 2023.
4
Metabolomics-directed nanotechnology in viral diseases management: COVID-19 a case study.代谢组学导向的纳米技术在病毒性疾病管理中的应用：以COVID-19为例
Pharmacol Rep. 2023 Oct;75(5):1045-1065. doi: 10.1007/s43440-023-00517-w. Epub 2023 Aug 16.
5
Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective.从进化角度看血管防御、止血、癌症和血小板生物学。
Cancer Metastasis Rev. 2022 Mar;41(1):147-172. doi: 10.1007/s10555-022-10019-5. Epub 2022 Jan 12.
6
Amino Acid Metabolism is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics Analysis.氨基酸代谢在因严重 COVID-19 住院时发生显著改变：来自纵向靶向代谢组学分析的结果。
Microbiol Spectr. 2021 Dec 22;9(3):e0033821. doi: 10.1128/spectrum.00338-21. Epub 2021 Dec 8.
7
Integrating heterogeneous data to facilitate COVID-19 drug repurposing.整合异质数据以促进 COVID-19 药物再利用。
Drug Discov Today. 2022 Feb;27(2):558-566. doi: 10.1016/j.drudis.2021.10.002. Epub 2021 Oct 16.
8
In silico drug repurposing in COVID-19: A network-based analysis.基于网络的 COVID-19 药物再利用的计算方法。
Biomed Pharmacother. 2021 Oct;142:111954. doi: 10.1016/j.biopha.2021.111954. Epub 2021 Jul 28.
9
Brain Mechanisms of COVID-19-Sleep Disorders.新冠病毒病与睡眠障碍的脑机制。
Int J Mol Sci. 2021 Jun 28;22(13):6917. doi: 10.3390/ijms22136917.
本文引用的文献
1
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
2
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
3
Adrenaline, ROSC and survival in patients resuscitated from in-hospital cardiac arrest.肾上腺素、ROSC 与院内心脏骤停患者复苏后的生存。
Resuscitation. 2019 Jul;140:64-71. doi: 10.1016/j.resuscitation.2019.05.004. Epub 2019 May 21.
4
Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome.破坏自我放大儿茶酚胺循环可减少细胞因子释放综合征。
Nature. 2018 Dec;564(7735):273-277. doi: 10.1038/s41586-018-0774-y. Epub 2018 Dec 12.
5
A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest.一项肾上腺素在院外心脏骤停中的随机试验。
N Engl J Med. 2018 Aug 23;379(8):711-721. doi: 10.1056/NEJMoa1806842. Epub 2018 Jul 18.
6
Phagocyte-derived catecholamines enhance acute inflammatory injury.吞噬细胞衍生的儿茶酚胺会加重急性炎症损伤。
Nature. 2007 Oct 11;449(7163):721-5. doi: 10.1038/nature06185. Epub 2007 Sep 30.
7
Stress hormone response during and after cardiopulmonary resuscitation.心肺复苏期间及之后的应激激素反应。
Anesthesiology. 1992 Oct;77(4):662-8. doi: 10.1097/00000542-199210000-00008.
Zotero 插件